Motley Fool Asset Management LLC grew its stake in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 9.7% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 122,592 shares of the company's stock after acquiring an additional 10,835 shares during the period. Motley Fool Asset Management LLC owned about 0.14% of HealthEquity worth $11,763,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently modified their holdings of the company. Wealthfront Advisers LLC acquired a new stake in HealthEquity during the 4th quarter worth about $10,304,089,000. Vanguard Group Inc. raised its position in HealthEquity by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 8,976,091 shares of the company's stock valued at $861,256,000 after acquiring an additional 99,624 shares in the last quarter. State Street Corp lifted its stake in HealthEquity by 0.8% in the third quarter. State Street Corp now owns 3,131,900 shares of the company's stock valued at $256,346,000 after acquiring an additional 23,613 shares during the last quarter. Geode Capital Management LLC grew its position in HealthEquity by 0.5% in the fourth quarter. Geode Capital Management LLC now owns 2,089,398 shares of the company's stock worth $200,522,000 after acquiring an additional 10,421 shares in the last quarter. Finally, Franklin Resources Inc. increased its stake in shares of HealthEquity by 0.7% during the 3rd quarter. Franklin Resources Inc. now owns 1,640,215 shares of the company's stock worth $139,369,000 after purchasing an additional 11,659 shares during the last quarter. Institutional investors and hedge funds own 99.55% of the company's stock.
Insiders Place Their Bets
In related news, Director Robert W. Selander sold 5,750 shares of the stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the sale, the director now directly owns 78,219 shares in the company, valued at $8,704,992.51. This represents a 6.85 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 2.20% of the company's stock.
Analyst Upgrades and Downgrades
HQY has been the subject of several analyst reports. JMP Securities upped their price objective on shares of HealthEquity from $105.00 to $107.00 and gave the stock a "market outperform" rating in a report on Tuesday, December 10th. Royal Bank of Canada upped their price target on HealthEquity from $100.00 to $105.00 and gave the stock an "outperform" rating in a research note on Tuesday, December 10th. Raymond James raised HealthEquity from an "outperform" rating to a "strong-buy" rating and lowered their price objective for the company from $120.00 to $115.00 in a report on Tuesday, March 25th. KeyCorp decreased their target price on HealthEquity from $120.00 to $110.00 and set an "overweight" rating for the company in a research report on Monday, March 24th. Finally, The Goldman Sachs Group dropped their price target on shares of HealthEquity from $107.00 to $94.00 and set a "neutral" rating on the stock in a research report on Thursday, March 27th. One research analyst has rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Buy" and an average target price of $112.58.
View Our Latest Analysis on HQY
HealthEquity Price Performance
Shares of HQY stock traded down $1.40 during trading hours on Tuesday, hitting $78.96. The company had a trading volume of 543,477 shares, compared to its average volume of 744,407. HealthEquity, Inc. has a 12 month low of $65.01 and a 12 month high of $115.59. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The firm's fifty day moving average is $101.18 and its 200 day moving average is $96.48. The firm has a market capitalization of $6.83 billion, a price-to-earnings ratio of 72.53, a PEG ratio of 1.60 and a beta of 0.49.
About HealthEquity
(
Free Report)
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Further Reading
Before you consider HealthEquity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthEquity wasn't on the list.
While HealthEquity currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
